Journal
JOINT BONE SPINE
Volume 72, Issue 6, Pages 461-465Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.jbspin.2005.09.002
Keywords
glucocorticoid-induced osteoporosis; bone absorptiometry; bisphosphonate
Categories
Ask authors/readers for more resources
Concern about glucocorticoid-induced osteoporosis is warranted in all patients who take glucocorticoids for longer than 3 months, in any dosage. Bone mineral density should be measured and additional risk factors sought in order to determine whether bisphosphonate therapy is appropriate. Bisphosphonate therapy should be considered in postmenopausal women and in patients whose bone densitometry T-score is less than -1.5. (C) 2005. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available